NCT07369973Not yet recruiting
Respiratory Biofeedback Added to Strengthening Training in Patients With Chronic Kidney Disease
Source: ClinicalTrials.gov · Last updated 27 Jan 2026
Brief summary (registry, in English)
The goal of this clinical trial is to learn whether diaphragmatic biofeedback added to respiratory muscle training improves clinical and functional outcomes in adults with chronic kidney disease. It will also evaluate the feasibility and acceptability of this intervention. The main questions it aims to answer are: Is diaphragmatic biofeedback added to respiratory muscle training acceptable and well tolerated in patients with chronic kidney disease? Does this intervention reduce respiratory symptoms and complications in this population? Does diaphragmatic biofeedback added to respiratory muscle training improve cardiorespiratory capacity and quality of life? Researchers will evaluate diaphragmatic biofeedback combined with respiratory muscle training and a placebo intervention based on conscious breathing to assess its effects. Participants will: * Perform the assigned intervention three times per day for 6 weeks * Follow a structured respiratory muscle training program with diaphragmatic biofeedback * Be monitored for symptoms, respiratory complications, and perceived quality of life throughout the study
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- First submitted
- 8 Jan 2026
- Start date
- Jan 2026
- Primary completion date
- Apr 2026
- Lead sponsor
- Universidad de Granada
- Diseases
- Chronic kidney disease
- NCT number
- NCT07369973
What you commit to
- Study type: Interventional
- Planned participants: 24
- From Jan 2026 to the primary completion date, Apr 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Recent thoracic or abdominal surgery (\<3 months)
Other illness
- Acute respiratory infection or unstable pulmonary disease
- Severe cognitive impairment or neurological condition limiting cooperation
- Unstable cardiovascular disease or contraindications to respiratory muscle training
- Significant visual impairment that prevents proper use of the biofeedback device
Other
- Participation in another interventional clinical trial during the study period
Who the study is looking for
- Adults aged ≥18 years
- Diagnosis of chronic kidney disease (CKD) at any stage
- Clinically stable condition, with no acute medical events in the previous 4 weeks
- Ability to understand and follow breathing and training instructions
- Willingness to participate and provide written informed consent
Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.